- Home
- TMQ vs DERM Comparison
TMQ vs DERM Comparison
Compare TMQ & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- DERM
- Stock Information
- Founded
- TMQ 2004
- DERM 2014
- Country
- TMQ Canada
- DERM United States
- Employees
- TMQ N/A
- DERM N/A
- Industry
- TMQ Precious Metals
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- TMQ Basic Materials
- DERM Health Care
- Exchange
- TMQ Nasdaq
- DERM Nasdaq
- Market Cap
- TMQ 83.6M
- DERM 87.4M
- IPO Year
- TMQ N/A
- DERM 2021
- Fundamental
- Price
- TMQ $1.20
- DERM $3.66
- Analyst Decision
- TMQ
- DERM Strong Buy
- Analyst Count
- TMQ 0
- DERM 3
- Target Price
- TMQ N/A
- DERM $9.50
- AVG Volume (30 Days)
- TMQ 224.1K
- DERM 63.2K
- Earning Date
- TMQ 02-07-2025
- DERM 11-12-2024
- Dividend Yield
- TMQ N/A
- DERM N/A
- EPS Growth
- TMQ N/A
- DERM N/A
- EPS
- TMQ N/A
- DERM N/A
- Revenue
- TMQ N/A
- DERM $57,771,000.00
- Revenue This Year
- TMQ N/A
- DERM N/A
- Revenue Next Year
- TMQ N/A
- DERM $36.49
- P/E Ratio
- TMQ N/A
- DERM N/A
- Revenue Growth
- TMQ N/A
- DERM N/A
- 52 Week Low
- TMQ $0.25
- DERM $2.85
- 52 Week High
- TMQ $1.40
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- TMQ 57.45
- DERM 29.46
- Support Level
- TMQ $1.10
- DERM $3.54
- Resistance Level
- TMQ $1.24
- DERM $4.00
- Average True Range (ATR)
- TMQ 0.06
- DERM 0.36
- MACD
- TMQ -0.00
- DERM -0.01
- Stochastic Oscillator
- TMQ 77.78
- DERM 12.77
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.